Default company panoramic image


RadisMed is a biomedical company developing orphan drugs for highly profitable markets with severe unmet medical needs.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Barcelona, España
  • Currency EUR
  • Founded April 2010
  • Employees 1
  • Website

Company Summary

RadisMed is a biomed start-up that develops drugs for the treatment of rare diseases with severe unmet medical needs. During its first business stage, the company is focused on cardiovascular diseases with high market potential.
RadisMed has acquired a technology from the University of San Diego and has established a solid network of industry collaborators. It is raising its first round of private investment to leverage with public funds.


  • Default avatar
    Alex Casta
    PhD, MBA

    BSc in Biochemistry, PhD in Pathobiology from Columbia University in New York and MBA from IESE, with experience both in the public and academic environment as well as in the private pharmaceutical and cosmetic industries. I have worked for several companies from the local industry including Lipotec and Advancell. In my last position at Fundació Bosch i Gimpera I was involved in the creation of several technology-based start-ups.

  • Default avatar
    Andreu Casali

    Biologist from the University of Barcelona(UB) and PhD in Biology also from UB. More tan 20 years experience as a researcher, most of them working with Drosophila. He was a Postdoctoral researcher at Columbia University in New York for 7 years publishing several papers in prestigious scientific journals. He was a CSIC researcher and currently he is working at the Biomedical Research Institute (IRB) at UB as an independent principal investigator.

  • Default avatar
    Olga Méndez

    She is a biochemist that obtained her PhD in Biochemistry from the Autonomous University of Barcelona. She has an extensive international experience working as a postdoctoral researcher, having completed projects in two prestigious institutions: New York University Medical Center and Columbia University. She is an expert in the research with mouse models and has published several papers in high-impact scientific journals.


  • Default avatar
    Default avatar

Previous Investors

  • Default avatar